Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
45
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

128
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
128
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the LUMIR challenge: The pathway to foundational registration models.

Medical image analysis·2026
Same author

DVNDTA: a dual virtual node based heterogeneous interaction model for accurate prediction of drug-target affinity.

BMC bioinformatics·2026
Same author

Mutant NPM1-regulated estrogen signaling promotes leukemia cell survival by upregulating HGF and represents a therapeutic vulnerability.

Biochemical pharmacology·2026
Same author

A recombinant adenoviral vector vaccine expressing the ORF2 capsid protein confers robust protection against chicken astrovirus infection.

Veterinary research·2026
Same author

ModeTv2: GPU-accelerated motion decomposition transformer for pairwise optimization in medical image registration.

Medical image analysis·2025
Same author

Deep Learning-Driven Protein-Ligand Binding Affinity Prediction: Data, Architecture, Training and Evaluation.

IEEE transactions on computational biology and bioinformatics·2025
Same journal

CoAff-DTI: Fine-grained drug-target interaction prediction using pre-trained language models and affinity-guided mechanisms.

Journal of biomedical informatics·2026
Same journal

Evaluation of temporal preservation in synthetic longitudinal patient data.

Journal of biomedical informatics·2026
Same journal

ARKE: An ontology-driven framework for automated mapping of local radiology procedure terms to the LOINC-RadLex playbook using large language model.

Journal of biomedical informatics·2026
Same journal

A validation-driven training controller for cross-lingual biomedical NER via reinforcement learning-based adaptive loss weighting.

Journal of biomedical informatics·2026
Same journal

ASP-HR: An Adaptive Spatial Perception and Hierarchical Reasoning mechanism for document-level biomedical relation extraction.

Journal of biomedical informatics·2026
Same journal

Beyond Accuracy: Safety-Centered guidelines for the evaluation of LLM-based therapy recommendation systems for chronic multimorbidity patients.

Journal of biomedical informatics·2026
See all related articles

Related Experiment Video

Updated: Jul 8, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

231

ACDNet: Attention-guided Collaborative Decision Network for effective medication recommendation.

Jiacong Mi1, Yi Zu1, Zhuoyuan Wang1

  • 1School of Computer Science and Engineering, Key Lab of Computer Network and Information Integration, MOE, Southeast University, Nanjing, 210018, Jiangsu, China.

Journal of Biomedical Informatics
|December 14, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces the Attention-guided Collaborative Decision Network (ACDNet) for improved medication recommendations from electronic health records (EHR). ACDNet enhances patient representation and medicine similarity, outperforming existing models.

Keywords:
Attention mechanismData miningElectronic health recordMedication recommendationTransformer

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

15.7K

Related Experiment Videos

Last Updated: Jul 8, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

231
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

15.7K

Area of Science:

  • Medical Informatics
  • Artificial Intelligence in Healthcare
  • Clinical Decision Support Systems

Background:

  • Medication recommendation from Electronic Health Records (EHR) is complex due to intricate medical data.
  • Existing personalized recommendation models often suffer from inadequate patient representation and fail to consider medication record similarity.
  • A gap exists in accurately modeling longitudinal patient data for precise medication suggestions.

Purpose of the Study:

  • To propose an Attention-guided Collaborative Decision Network (ACDNet) for enhanced medication recommendation from EHR.
  • To improve patient representation and incorporate medication-medicine similarity for more accurate recommendations.
  • To validate the effectiveness of ACDNet against state-of-the-art models using real-world medical datasets.

Main Methods:

  • Developed ACDNet, integrating attention mechanisms and Transformer architecture to model historical patient visits globally and locally.
  • Implemented a collaborative decision framework that leverages the similarity between medication records and medicine representations.
  • Evaluated ACDNet on the MIMIC-III and MIMIC-IV datasets.

Main Results:

  • ACDNet significantly outperformed existing state-of-the-art models in medication recommendation tasks, achieving superior Jaccard, PR-AUC, and F1 scores.
  • Ablation experiments confirmed the significant contribution of each module within the ACDNet architecture.
  • A case study demonstrated the practical applicability and value of ACDNet in real-world healthcare settings.

Conclusions:

  • ACDNet offers a superior approach to medication recommendation by effectively capturing patient conditions and medication histories.
  • The model's ability to consider medication record similarity enhances recommendation accuracy and clinical utility.
  • ACDNet shows strong potential for integration into clinical decision support systems for personalized patient care.